Long-term evaluation of lipid profile and oral glucose tolerance test in Norplant users
Fabio F Araujo1, Geraldo Rodrigues de Lima, Cristina A F Guazzelli
1Department of Obstetrics and Gynecology, Universidade Federal de São Paulo-Escola Paulista de Medicina, Brazil. arujoff@aol.com
Purpose:
This study reports the results of the lipid profile and oral glucose tolerance test (OGTT) in 46 normal patients tested before and after 5 years of Norplant use.
Results:
After 5 years, there was a substantial decrease of 28.9% in high-density lipoprotein cholesterol levels and a similar but less pronounced fall of 7.1% in the total cholesterol levels. The Castelli 1 index did not vary, and the triglycerides and low-density lipoprotein cholesterol levels remained normal and unchanged throughout the study period. All the mean values of OGTT were significantly lower after 5 years, except for the 90-min glycemia.
Conclusion:
These findings indicate that long-term Norplant use does not increase cardiovascular risks.
Related Concept Videos
Hyperglycemia
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Type 2 and Gestational
